NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting
Neuropace, Inc. (NPCE)
Company Research
Source: GlobeNewswire
RNS System to be featured in over 70 scientific presentations and posters Pre-book a demonstration in the NeuroPace Tech Suite to see the latest innovations of the RNS System which simplify the treatment experience for physicians and patients NeuroPace’s Booth #2119 MOUNTAIN VIEW, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- December 4, 2024 – NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will have a substantial presence at the 2024 American Epilepsy Society Annual Meeting (AES 2024). The event is being held at the Los Angeles Convention Center from December 6 - 10, 2024. “The AES annual meeting is a significant event for NeuroPace and our RNS System. I am excited to announce that the NeuroPace team has put together a strong presence at AES featuring new clinical data on the RNS System, development of AI tools to analyze the intracranial EEG data obtained by the device, pr
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at JPMorgan Chase & Co. from $9.00 to $14.00. They now have an "overweight" rating on the stock.MarketBeat
- NeuroPace to Host Investor Day on January 28th in New York CityGlobeNewswire
- NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome [Yahoo! Finance]Yahoo! Finance
NPCE
Earnings
- 11/12/24 - Beat
NPCE
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/12/24 - Form 10-Q
- NPCE's page on the SEC website